Table 1. Baseline clinical information of patients with CTEPH (n = 53).
Baseline parameters | |
Age (years) | 60.6±11.4 |
Gender (female/male) | 37/16 |
Body surface area (m2) | 1.60±0.21 |
CT-RHC Interval (day, min-max) | 2–16 |
Oxygen therapy | 40 (1–6 L/min) |
Months from onset of symptoms to CT, median (range) | 15 (4–306) |
Vasodilators | |
Oral prostaglandin I2 | 12 |
PhosphodiesteraseV inhibitor | 15 |
Endothelin antagonist | 8 |
Monotherapy | 14 |
Double combination therapy | 11 |
Triple combination therapy | 0 |
Data are presented as mean±SD.